2024-05-01 2025-04-30 false Capium Accounts Production 1.1 14027298 2024-05-01 2025-04-30 14027298 bus:FullAccounts 2024-05-01 2025-04-30 14027298 bus:FRS102 2024-05-01 2025-04-30 14027298 bus:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 14027298 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 14027298 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 14027298 2024-05-01 2025-04-30 14027298 2025-04-30 14027298 bus:RegisteredOffice 2024-05-01 2025-04-30 14027298 core:WithinOneYear 2025-04-30 14027298 core:AfterOneYear 2025-04-30 14027298 1 2024-05-01 2025-04-30 14027298 bus:Director1 2024-05-01 2025-04-30 14027298 bus:Director1 2025-04-30 14027298 bus:Director1 2023-05-01 2024-04-30 14027298 2023-05-01 14027298 bus:LeadAgentIfApplicable 2024-05-01 2025-04-30 14027298 2023-05-01 2024-04-30 14027298 2024-04-30 14027298 core:WithinOneYear 2024-04-30 14027298 core:AfterOneYear 2024-04-30 14027298 bus:EntityAccountantsOrAuditors 2023-05-01 2024-04-30 14027298 bus:OrdinaryShareClass1 2024-05-01 2025-04-30 14027298 bus:OrdinaryShareClass1 2025-04-30 14027298 bus:OrdinaryShareClass1 2023-05-01 2024-04-30 14027298 bus:OrdinaryShareClass1 2024-04-30 14027298 core:FurnitureFittings 2024-05-01 2025-04-30 14027298 core:FurnitureFittings 2025-04-30 14027298 core:FurnitureFittings 2024-04-30 14027298 core:ComputerEquipment 2024-05-01 2025-04-30 14027298 core:ComputerEquipment 2025-04-30 14027298 core:ComputerEquipment 2024-04-30 14027298 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-04-30 14027298 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-04-30 14027298 core:CostValuation core:Non-currentFinancialInstruments 2025-04-30 14027298 core:CostValuation core:Non-currentFinancialInstruments 2024-04-30 14027298 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-04-30 14027298 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-04-30 14027298 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-04-30 14027298 core:Non-currentFinancialInstruments 2025-04-30 14027298 core:Non-currentFinancialInstruments 2024-04-30 14027298 core:RetainedEarningsAccumulatedLosses 2025-04-30 14027298 core:RetainedEarningsAccumulatedLosses 2024-04-30 14027298 dpl:Item1 2024-05-01 14027298 dpl:Item1 2025-04-30 14027298 dpl:Item1 2023-05-01 14027298 dpl:Item1 2024-04-30 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 14027298
IMPLANTS BY DR UZMAN LIMITED
Unaudited Financial Statements
Period of accounts Start date: 01 May 2024 End date: 30 April 2025

IMPLANTS BY DR UZMAN LIMITED Contents Page For the year ended 30 April 2025
Company information | 1
Income statement | 2
Statement of financial position | 3
Notes to the financial statements | 4

IMPLANTS BY DR UZMAN LIMITED Company Information For the year ended 30 April 2025
Director | Dr Uzman UL HAQ
Registered Number | 14027298
Registered Office | 61 High Street Great Linford Milton Keynes England MK14 5AX
Accountants | Salhan Accountants Ltd 54 Hagley Road Edgbaston Birmingham B16 8PE
1

IMPLANTS BY DR UZMAN LIMITED Income Statement For the year ended 30 April 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Turnover |  | 278,662 |  | 252,112
Cost of sales |  | (140,159) |  | (122,692)
Gross profit |  | 138,503 |  | 129,420
Administrative expenses |  | (43,779) |  | (41,546)
Operating profit |  | 94,724 |  | 87,874
Profit/(Loss) on ordinary activities before taxation |  | 94,724 |  | 87,874
Tax on profit on ordinary activities |  | (27,722) |  | (19,738)
Profit/(Loss) for the financial year |  | 67,002 |  | 68,136
2

IMPLANTS BY DR UZMAN LIMITED Statement of Financial Position As at 30 April 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Tangible fixed assets | 3 | 5,606 |  | 5,894
|  | 5,606 |  | 5,894
Current assets |  |  |
Debtors | 4 | 18,974 |  | 641
Cash at bank and in hand |  | 12,421 |  | 18,122
|  | 31,395 |  | 18,763
Creditors: amount falling due within one year | 5 | (29,890) |  | (18,881)
Net current assets |  | 1,505 |  | (118)
Total assets less current liabilities |  | 7,111 |  | 5,776
Provisions for liabilities | 6 | (1,474) |  | (1,474)
Net assets |  | 5,637 |  | 4,302
Capital and reserves |  |  |
Profit and loss account |  | 5,637 |  | 4,302
Shareholders' funds |  | 5,637 |  | 4,302
For the year ended 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. The financial statements were approved by the director on 15 January 2026 and were signed by:
------------------------------- Dr Uzman UL HAQ Director
3

IMPLANTS BY DR UZMAN LIMITED Notes to the Financial Statements For the year ended 30 April 2025
General Information IMPLANTS BY DR UZMAN LIMITED is a private company, limited by shares, registered in , registration number 14027298, registration address 61 High Street, Great Linford, Milton Keynes, England, MK14 5AX. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Operating lease rentals Rentals payable under operating leases are charged against income on a straight line basis over the lease term. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted Intangible assets Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Fixtures and Fittings | 10% Reducing Balance
Computer Equipment | 25% Reducing Balance
Provisions Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2. | Average number of employees Average number of employees during the year was 1 (2024 : 1).
3. | Tangible fixed assets
Cost or valuation | Fixtures and Fittings |  | Computer Equipment |  | Total
| £ |  | £ |  | £
At 01 May 2024 | 7,215 |  | - |  | 7,215
Additions | - |  | 402 |  | 402
Disposals | - |  | - |  | -
At 30 April 2025 | 7,215 |  | 402 |  | 7,617
Depreciation
At 01 May 2024 | 1,321 |  | - |  | 1,321
Charge for year | 589 |  | 101 |  | 690
On disposals | - |  | - |  | -
At 30 April 2025 | 1,910 |  | 101 |  | 2,011
Net book values
Closing balance as at 30 April 2025 | 5,305 |  | 301 |  | 5,606
Opening balance as at 01 May 2024 | 5,894 |  | - |  | 5,894
4. | Debtors: amounts falling due within one year
| 2025 £ |  | 2024 £
--- | --- | --- | ---
Other Debtors | 641 |  | 641
Directors' Current Accounts | 18,333 |  | 0
| 18,974 |  | 641
5. | Creditors: amount falling due within one year
| 2025 £ |  | 2024 £
--- | --- | --- | ---
Bank Loans & Overdrafts (Secured) | (3,354) |  | 0
American Express | 4,896 |  | (3,922)
Corporation Tax | 28,348 |  | 19,445
Accrued Expenses | 0 |  | 3,358
| 29,890 |  | 18,881
6. | Provisions for liabilities
| 2025 £ |  | 2024 £
--- | --- | --- | ---
Deferred Tax | 1,474 |  | 1,474
| 1,474 |  | 1,474
7. | Share Capital Authorised 100 Class A shares of £1.00 each
Allotted, called up and fully paid | 2025 £ |  | 2024 £
--- | --- | --- | ---
100 Class A shares of £1.00 each | 100 |  | 100
| 100 |  | 100
4